Menu
With 1 in 2 individuals likely to face a cancer diagnosis in their lifetime, the challenge of effective diagnosis and treatment, particularly in lung cancer, is more crucial than ever. Lung cancer’s impact is felt globally, necessitating advancements in diagnostic methods.
Precision cancer medicine, targeting cancer cells based on their genetic alterations, offers a significant improvement over traditional methods, which often harm healthy cells and cause side effects. This approach is less invasive and results in fewer side effects, marking a major advance in cancer treatment.
Precision cancer medicine is limited by current diagnostic methods. Traditional tissue-based biopsies, essential for enabling precision treatments, are often invasive, painful, and carry a high failure rate of 30%. These factors delay treatment, escalate costs, and only offer a partial view of the tumor, significantly constraining the efficacy and scope of precision medicine.
PreciousMD is leading the way in radiogenomics, blending radiology and genomics to overcome traditional diagnostic limits. Our approach is non-invasive and risk-free, offering real-time results and a comprehensive tumor view, crucially enhancing precision medicine in cancer care.
FIND OUT WHAT’S HAPPENING
